Catherine  Corrigan net worth and biography

Catherine Corrigan Biography and Net Worth

CEO of Exponent

Dr. Catherine Corrigan is the President and Chief Executive Officer of Exponent. Dr. Corrigan joined the Company in 1996, was promoted to Principal in the Biomechanics Practice in 2002, and to Corporate Vice President in 2005. 

In 2012, Dr. Corrigan was appointed Vice President of Exponent's Transportation Group, overseeing the company's Vehicle Engineering, Biomechanics, Human Factors, and Statistical and Data Sciences practices, as well as Visual Communications. She was appointed President of the Company in 2016 and Chief Executive Officer in 2018.

Dr. Corrigan has consulted in the area of injury biomechanics and on issues related to motor vehicle and product safety for more than twenty years. Dr. Corrigan holds a Ph.D. in Medical Engineering from the Harvard-MIT Division of Health Sciences and Technology, an M.S. in Mechanical Engineering from MIT, and a BS.E. in Bioengineering from the University of Pennsylvania.

Dr. Corrigan addresses issues involving the biomechanics of human injury, with expertise in the areas of human tolerance and occupant kinematics. Her work includes analysis of traumatic injuries associated with transportation, heavy equipment, falls, consumer products, and the workplace. Her research activities have included studies of occupant kinematics and injuries in the automotive environment, bone and joint mechanics, pediatric biomechanics, and the mechanics of central nervous system injury. Dr. Corrigan's experience also includes computerized accident simulation and field accident data analysis.

Dr. Corrigan has held appointments as Adjunct Professor in the Department of Mechanical Engineering at Temple University, and as Visiting Lecturer in the Department of Mechanical and Aerospace Engineering at Princeton University. Prior to joining Exponent, Dr. Corrigan was a researcher at the Orthopedic Biomechanics Laboratory of Beth Israel Hospital and Harvard Medical School.

What is Catherine Corrigan's net worth?

The estimated net worth of Catherine Corrigan is at least $6.19 million as of November 17th, 2025. Dr. Corrigan owns 83,429 shares of Exponent stock worth more than $6,194,603 as of December 4th. This net worth estimate does not reflect any other assets that Dr. Corrigan may own. Additionally, Dr. Corrigan receives an annual salary of $1,670,000.00 as CEO at Exponent. Learn More about Catherine Corrigan's net worth.

How old is Catherine Corrigan?

Dr. Corrigan is currently 55 years old. There are 4 older executives and no younger executives at Exponent. Learn More on Catherine Corrigan's age.

What is Catherine Corrigan's salary?

As the CEO of Exponent, Inc., Dr. Corrigan earns $1,670,000.00 per year. Learn More on Catherine Corrigan's salary.

How do I contact Catherine Corrigan?

The corporate mailing address for Dr. Corrigan and other Exponent executives is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. Exponent can also be reached via phone at (650) 326-9400 and via email at [email protected]. Learn More on Catherine Corrigan's contact information.

Has Catherine Corrigan been buying or selling shares of Exponent?

In the last ninety days, Catherine Corrigan has sold $674,333.60 in Exponent stock. Most recently, Catherine Corrigan sold 4,900 shares of the business's stock in a transaction on Monday, November 17th. The shares were sold at an average price of $70.39, for a transaction totalling $344,911.00. Following the completion of the sale, the chief executive officer now directly owns 83,429 shares of the company's stock, valued at $5,872,567.31. Learn More on Catherine Corrigan's trading history.

Who are Exponent's active insiders?

Exponent's insider roster includes George Brown (Director), Catherine Corrigan (CEO), Eric Guyer (Insider), Bradley James (VP), Paul Johnston (Director), Harri Kytömaa (VP), Carol Lindstrom (Director), Steven Murray (VP), John Pye (VP), Joseph Rakow (VP), Richard Reiss (VP), Maureen Reitman (VP), Joseph Sala (VP), Richard Schlenker, Jr. (CFO), and Sally Shepard (Insider). Learn More on Exponent's active insiders.

Are insiders buying or selling shares of Exponent?

In the last twelve months, insiders at the business services provider sold shares 9 times. They sold a total of 29,229 shares worth more than $2,116,264.51. The most recent insider tranaction occured on November, 17th when CEO Catherine Corrigan sold 4,900 shares worth more than $344,911.00. Insiders at Exponent own 1.6% of the company. Learn More about insider trades at Exponent.

Information on this page was last updated on 11/17/2025.

Catherine Corrigan Insider Trading History at Exponent

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/17/2025Sell4,900$70.39$344,911.0083,429View SEC Filing Icon  
10/15/2025Sell4,930$66.82$329,422.6082,753View SEC Filing Icon  
9/15/2025Sell4,905$69.91$342,908.5582,753View SEC Filing Icon  
8/14/2025Sell4,896$71.09$348,056.6481,342View SEC Filing Icon  
5/11/2018Sell4,448$89.53$398,229.4427,188View SEC Filing Icon  
5/27/2016Sell3,000$52.68$158,040.0020,898View SEC Filing Icon  
5/24/2016Sell4,276$51.33$219,487.0823,898View SEC Filing Icon  
5/20/2016Sell5,950$50.10$298,095.0028,174View SEC Filing Icon  
5/18/2016Sell6,722$50.32$338,251.0434,124View SEC Filing Icon  
2/25/2016Sell2,000$46.89$93,780.0033,852View SEC Filing Icon  
8/27/2015Sell3,000$42.27$126,810.0038,520View SEC Filing Icon  
5/29/2014Sell2,500$70.06$175,150.00View SEC Filing Icon  
8/23/2013Sell1,498$66.01$98,882.9817,034View SEC Filing Icon  
8/22/2013Sell5,366$66.53$356,999.9819,282View SEC Filing Icon  
See Full Table

Catherine Corrigan Buying and Selling Activity at Exponent

This chart shows Catherine Corrigan's buying and selling at Exponent by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Exponent Company Overview

Exponent logo
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.
Read More

Today's Range

Now: $74.25
Low: $73.69
High: $75.15

50 Day Range

MA: $69.50
Low: $65.27
High: $74.25

2 Week Range

Now: $74.25
Low: $63.81
High: $98.32

Volume

377,408 shs

Average Volume

364,016 shs

Market Capitalization

$3.70 billion

P/E Ratio

36.22

Dividend Yield

1.63%

Beta

0.82